Moreover, treprostinil, a prostacyclin mimetic analogue that also acts on prostaglandin receptors, in particular, on prostaglandin E receptor 2 (EP2) and prostaglandin D receptor 1 (DP1), is under evaluation for IPF. The gene discussed is PTGER2; the disease is idiopathic pulmonary fibrosis.